Skip to contentA
Accendra Health Inc
A
ACHAccendra Health Inc Q3 2019 · 10-Q
Revenue$2.29B$2.29B−7.0% vs Q3 2018 Net Income$1.22M$1.22MN/M vs Q3 2018 EPS Diluted$0.02$0.02N/M vs Q3 2018 Gross Profit$280,622,000−20.4% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Accendra Health Inc · CIK 75252 · Engraved from SEC EDGAR
Operating Cash Flowderived$110,091,000+44.4% Free Cash Flowderived$99,887,000+57.1% Margins · derivedGross margin12.2%−2.1 pt vs Q3 2018
Operating margin1.1%+0.3 pt vs Q3 2018
Net margin0.1%+0.1 pt vs Q3 2018
ended Sep 30, 2019 · filed Nov 6, 2019 · 37 d after period end